REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 117 filers reported holding REVOLUTION MEDICINES INC in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $161,707 | +9.1% | 5,842 | +5.5% | 0.01% | +14.3% |
Q2 2023 | $148,195 | +47.1% | 5,540 | +19.1% | 0.01% | +40.0% |
Q1 2023 | $100,719 | -9.3% | 4,650 | -0.2% | 0.01% | 0.0% |
Q4 2022 | $111,025 | +25.6% | 4,661 | +4.0% | 0.01% | +25.0% |
Q3 2022 | $88,365 | +16.1% | 4,481 | +14.8% | 0.00% | +33.3% |
Q2 2022 | $76,108 | -23.6% | 3,905 | 0.0% | 0.00% | -25.0% |
Q1 2022 | $99,617 | -76.1% | 3,905 | -76.4% | 0.00% | -33.3% |
Q4 2021 | $416,513 | -8.5% | 16,548 | 0.0% | 0.01% | -14.3% |
Q3 2021 | $455,235 | -13.3% | 16,548 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $525,234 | +3.1% | 16,548 | +49.0% | 0.01% | -12.5% |
Q1 2021 | $509,681 | +12.6% | 11,109 | -2.9% | 0.01% | +14.3% |
Q4 2020 | $452,751 | +13.8% | 11,436 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $397,973 | +154.2% | 11,436 | +130.6% | 0.01% | +133.3% |
Q2 2020 | $156,556 | +44.1% | 4,959 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $108,652 | – | 4,959 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $104,824,198 | 43.76% |
Column Group LLC | 4,577,840 | $99,156,014 | 35.85% |
Mass General Brigham, Inc | 338,191 | $7,325 | 5.71% |
Boxer Capital, LLC | 4,684,264 | $101,461 | 4.98% |
BVF INC/IL | 4,955,588 | $107,338,036 | 3.92% |
DAFNA Capital Management LLC | 575,785 | $12,471,503 | 3.74% |
EcoR1 Capital, LLC | 5,352,183 | $115,928,284 | 3.73% |
Casdin Capital, LLC | 1,810,000 | $39,204,600 | 3.23% |
Artal Group S.A. | 2,070,988 | $44,858 | 2.66% |
Integral Health Asset Management, LLC | 345,000 | $7,472,700 | 1.50% |